ARS Pharmaceuticals Inc (SPRY)
11.34
+0.26
(+2.35%)
USD |
NASDAQ |
Jan 07, 16:00
11.34
0.00 (0.00%)
After-Hours: 20:00
ARS Pharmaceuticals Profit Margin (Quarterly): -925.0% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Exelixis Inc | 21.87% |
| Assembly Biosciences Inc | -140.4% |
| Protagonist Therapeutics Inc | -710.4% |
| Precision BioSciences Inc | -2.85K% |
| Avidity Biosciences Inc | -3.44K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -22.16% |
| Return on Assets | -21.37% |
| Return on Invested Capital | -22.16% |
| Gross Profit Margin (Quarterly) | 94.58% |
| Operating Margin (Quarterly) | -1.05K% |
| Return on Net Operating Assets | -884.8% |